The device will be used to treat bloodstream infections that are the leading cause of death in critically ill patients and soldiers injured in combat.
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that it was awarded a $9.25 million contract from the Defense Advanced Research Projects Agency (DARPA) to further advance a blood-cleansing technology developed at the Institute with prior DARPA support, and help accelerate its translation to humans as a new type of sepsis therapy.
The device will be used to treat bloodstream infections that are the leading cause of death in critically ill patients and soldiers injured in combat.
To rapidly cleanse the blood of pathogens, the patient’s blood is mixed with magnetic nanobeads coated with a genetically engineered version of a human blood ‘opsonin’ protein that binds to a wide variety of bacteria, fungi, viruses, parasites, and toxins. It is then flowed through microchannels in the device where magnetic forces pull out the bead-bound pathogens without removing human blood cells, proteins, fluids, or electrolytes — much like a human spleen does. The cleansed blood then flows back to the patient.
“In just a few years we have been able to develop a suite of new technologies, and to integrate them to create a powerful new device that could potentially transform the way we treat sepsis,” said Wyss founding director and project leader, Don Ingber, M.D., Ph.D. “The continued support from DARPA enables us to advance our device manufacturing capabilities and to obtain validation in large animal models, which is precisely what is required to enable this technology to be moved towards testing in humans.”
The Latest Bing News on:
Sepsis
- AHA blog shares ways to prevent pediatric sepsison April 26, 2024 at 12:18 pm
Pediatric sepsis is "an aggressive and unrelenting adversary that knows neither geographic nor demographic bounds," writes Chris DeRienzo, M.D., AHA’s senior vice president and chief physician ...
- Prevention Is the Prescription for Reducing Pediatric Sepsison April 26, 2024 at 9:52 am
As a pediatrician, I've seen the impact of pediatric sepsis firsthand — it's an aggressive and unrelenting adversary that knows neither geographic nor demographic bounds. Sepsis is also harder to ...
- Boy, 3, would have survived sepsis with quick hospital referralon April 26, 2024 at 1:58 am
Boy, 3, would have survived sepsis with quick hospital referral - Isaac Onyeka, from Loughton, became unresponsive at home after contracting a Strep A infection which led to sepsis ...
- Jonathan Aitken: I died three times on operating table from sepsison April 25, 2024 at 1:50 pm
Jonathan Aitken, the former Tory minister jailed for perjury in 1999 who is now a prison chaplain, said he died three times on an operating table from sepsis ...
- Ingredient found in cakes, chewing gum and drinks is ‘toxic to the gut and could trigger sepsis’on April 25, 2024 at 7:54 am
FOOD sweetener neotame can damage the gut and cause serious illness, a study suggests. The e-number chemical is thousands of times sweeter than sugar and is increasingly used in place of ...
- Deepull debuts point of care sepsis detection UllCORE systemon April 25, 2024 at 4:41 am
"Deepull debuts point of care sepsis detection UllCORE system" was originally created and published by Medical Device Network, a GlobalData owned brand.
- deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024on April 25, 2024 at 12:28 am
UllCORE is designed to transform life-saving clinical decision making for sepsis patients Barcelona, Spain – 25 April 2024 – deepull, a medical diagnostics company developing culture-free diagnostic ...
- Sepsis Diagnostics Market is Expected to Reach $890 million | MarketsandMarkets™on April 24, 2024 at 5:29 am
Sepsis Diagnostics market in terms of revenue was estimated to be worth $634 million in 2024 and is poised to reach $890 million by 2029, growing at a CAGR of 7.0% from 2024 to 2029 according to a ...
- Medical Monday: Sepsison April 23, 2024 at 9:36 am
In this week’s Medical Monday. we learn more about Sepsis Syndrome and how the body can have negative responses to an infection.
- Superfit gran's sepsis warning after 'flu' left her fighting for life just days lateron April 23, 2024 at 1:35 am
Dee Thomas, 65, from Perthshire, was left fighting for her life after what she thought was a bout of 'flu' turned out to be a serious infection that began attacking her heart and spine.
The Latest Google Headlines on:
Sepsis
[google_news title=”” keyword=”sepsis ” num_posts=”10″ blurb_length=”0″ show_thumb=”left”] [/vc_column_text]The Latest Bing News on:
Sepsis therapeutic device
- AHA blog shares ways to prevent pediatric sepsison April 26, 2024 at 12:18 pm
Pediatric sepsis is "an aggressive and unrelenting adversary that knows neither geographic nor demographic bounds," writes Chris DeRienzo, M.D., AHA’s senior vice president and chief physician ...
- Adjunctive Corticosteroid Therapy in Pediatric Severe Sepsis: Observations from the RESOLVE study*on April 24, 2024 at 5:00 pm
Objective: To assess whether corticosteroids, used as adjunctive therapy for pediatric severe sepsis, is associated with improved outcomes. Design: Retrospective cohort study examining the ...
- Irish scientists develop Sepsis breakthroughon April 18, 2024 at 9:08 am
Having seen numerous attempts to tackle the escalating sepsis crisis fail, Kerrigan believed the solution was not more powerful antibiotics but a completely new type of drug therapy that would ...
- Irish team develops therapy for deadly sepsis crisison April 17, 2024 at 10:00 pm
Inthelia Therapeutics, founded by two top Irish scientists, is switching focus to block infection getting a grip on patients in the first place Inthelia Therapeutics co-founders Prof Steve ...
- Worse Sepsis Outcomes Linked to Higher Pro- and Anti-Inflammatory Cytokine Levelson April 16, 2024 at 5:01 pm
Patients with sepsis with high levels of pro-inflammatory ... pharmaceutical, and/or device companies. Please see the original reference for a full list of authors’ disclosures.
- New device can treat injury from sepsison April 13, 2024 at 4:03 am
Prior to February 2024, limited therapeutics were available to treat sepsis, a life threatening organ dysfunction caused by a dysregulated host response to infection. Now, a new, commercially viable ...
- Enlivex reports positive data from Phase II sepsis treatment trialon April 12, 2024 at 11:38 am
Throughout the different sepsis patient subgroups and risk categories, the analyses comparing Allocetra to the placebo demonstrated that the therapy ... and Medical Devices (AEMPS) for the ...
- Sepsis signature shifts speed of diagnosison April 9, 2024 at 5:00 pm
Sepsis and septic shock patients could experience faster diagnosis and better outcomes thanks to new Western Australian research. Blood plasma metabolic phenotyping has been successfully used to ...
- Prenosis nabs de novo nod for AI-powered sepsis risk toolon April 5, 2024 at 6:08 am
The diagnostics startup Prenosis has scored a groundbreaking green light from the FDA for an artificial intelligence-powered tool that aims to spot the early signs of sepsis. The agency’s de ...
- Researchers identify a promising therapeutic target for sepsison February 5, 2023 at 4:00 pm
Autophagy can alleviate sepsis by restoring intestinal barrier function, and now researchers have identified a potential therapeutic target to promote this process. Sepsis is one of the most serious ...
The Latest Google Headlines on:
Sepsis therapeutic device
[google_news title=”” keyword=”sepsis therapeutic device” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
